Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

Boris Johnson to unveil ‘talent visa’ for high-flying scientists

Global Talent visa due to come into effect on 20 February

- PMLiVE

AZ says Brilinta hits the mark in new stroke trial

Drug met primary endpoint in phase 3 THALES trial

- PMLiVE

Havas Lynx Group and VCCP Health win big at PM Society Awards

Edwards Lifesciences and Teva top the pharma leader board

Tackling antimicrobial resistance on multiple fronts

An urgent change of direction is needed in how we respond to AMR

- PMLiVE

TBWAWorldHealth London announces restructure and key hires

Sarah Williams, Britt Nyman and Kavita Goswami join as business unit leads

- PMLiVE

Sanofi completes acquisition of immuno-oncology specialist Synthorx

Synthorx is now fully owned by the French drugmaker

- PMLiVE

Happy Chinese New Year 2020 – The Year of The Rat

A fond farewell to The Year of the Pig

Page & Page Health

- PMLiVE

SIGHT project team wins top recognition award

SIGHT project team scoops the Bedrock Group CEO Team Award 2019

Bedrock Healthcare Communications

- PMLiVE

UK biotech funding falls 40% between 2018 and 2019

Drop attributed to global uncertainty and Neil Woodford scandal

- PMLiVE

QiC Dermatology is now open for entry

Supported by The British Skin Foundation, The Primary Care Dermatology Society

- PMLiVE

The digital shift in pharma marketing

Indegene’s surveys in 2016 and 2019 show a spike in digital spend

AstraZeneca AZ

AZ’s Imfinzi scores orphan drug status in liver cancer

Company is looking to gain approval in the first-line advanced setting

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links